Registration Dossier
Registration Dossier
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 265-314-4 | CAS number: 65036-46-6
Endpoint summary
Administrative data
Description of key information
An in vivo skin sensitization study according to OECD 429 (LLNA) showed no skin sensitization in the read-across substance.
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study with acceptable restrictions
- Justification for type of information:
- Data from the alternative salt form of the registered substance is used to satisfy the data requirement. Jusitifcation is attached in section 13.
- Reason / purpose for cross-reference:
- read-across source
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Version / remarks:
- 22 July 2010
- Deviations:
- no
- Qualifier:
- according to guideline
- Guideline:
- EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay)
- Version / remarks:
- 06 July 2012
- Deviations:
- no
- Type of study:
- mouse local lymph node assay (LLNA)
- Species:
- mouse
- Strain:
- CBA
- Remarks:
- /CaOlaHsd
- Sex:
- female
- No. of animals per dose:
- 5
- Positive control results:
- Test group 3 (10 % PC)= SI 2.79
Test group 4 (25 %PC) = SI 7.84
EC3 value = 10.6%
Ear skin irritation: cut-off value of 1.1 for the ear weight index - Key result
- Parameter:
- SI
- Value:
- 1.02
- Variability:
- 0.59 - 1.47
- Test group / Remarks:
- 1 % test item
- Key result
- Parameter:
- SI
- Value:
- 0.86
- Variability:
- 0.20 - 1.43
- Test group / Remarks:
- 2 % test item
- Key result
- Parameter:
- SI
- Value:
- 1.32
- Variability:
- 0.76 - 2.00
- Test group / Remarks:
- 5 % test item
- Cellular proliferation data / Observations:
- EC3 CALCULATION
The EC3 value could not be calculated, since all S.I.´s are below the threshold value of 3.
CLINICAL OBSERVATIONS:
Viability / Mortality
No deaths occurred during the study period.
Clinical signs
No signs of systemic toxicity were observed during the study period. On day 6, the animals treated with the low and high dose of the test item and some of the animals treated with the mid dose of the test item showed slightly scaly ears. Moreover, two animals of the mid dose group (animals 14 and 15) and one animal of the high dose group (animal 19) showed slight eschar formation. A possible erythema of the ear skin could not be determined in the mid and high dose group, due to the colour of the test item.
Body weights
The body weight of the animals, recorded prior to the first application and prior to treatment with 3HTdR, was within the range commonly recorded for animals of this strain and age.
Lymph node weights and cell counts
The measured lymph node weights and –cell counts of all animals treated were recorded after sacrifice. A statistically significant or biologically relevant increase in lymph node weights or – cell counts was not observed in any of the test item treated groups in comparison to the vehicle control group. For BALB/c mice, a cut-off value for the lymph node cell count index of 1.55 was reported for a positive response. The indices determined for the lymph node cell count did not reach or exceed this threshold.
Ear weights
The measured ear weight of all animals treated was recorded on test day 6 (after necropsy). A biologically relevant or statistically significant increase in ear weights was not observed. Furthermore, the cut-off value (1.1) of the ear weight index for a positive response regarding ear skin irritation reported for BALB/c mice was not reached or exceeded in any of the treated groups. - Interpretation of results:
- GHS criteria not met
- Conclusions:
- The registered substance is considered not skin sensitising based on an LLNA study on the read-across substance.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
The CLP classification criteria are not met.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
